Masatomo Toyama, Hideaki Kouzaki, Takeshi Shimizu, Hitoshi Hirakawa, Mikio Suzuki. Butyrate inhibits type 2 inflammation in eosinophilic chronic rhinosinusitis. Biochemical and Biophysical Research Communications. 2024
Hirakawa H, Ikegami T, Touyama M, Ooshiro Y, Higa T, Higa T, Agena S, Kinjyo H, Kondo S, Kise N, et al. p16 Overexpression in Sinonasal Squamous Cell Carcinoma: Association with Human Papillomavirus and Prediction of Survival Outcomes. Journal of Clinical Medicine. 2023. 12. 21. 6861
Tanaka, K, Hirakawa, H, Suzuki, M, Higa, T, Agena, S, Hasegawa, N, Kawakami, J, Toyama, M, Higa, T, Kinjyo, H, et al. Programmed Cell Death-1 Antibody Treatment Effects in Head and Neck Cancer. Current Oncology. 2023. 2023,. 30. 5409-5424